June 19, 2009 - Increased utilization of advanced medical imaging, such as CT and MRI, between 1991 and 2004 improved life expectancy rates by a significant factor, actually greater than the increases in mortality caused by obesity over the same timeframe, according to a recent study conducted by Columbia University professor Frank Lichtenberg, Ph.D.

June 18, 2009 – aycan Medical systems announced the installation of an advanced RIS/PACS system at Rural Radiology of Bemidji in Minn., providing best in class turn-key solution to its customers, said aycan.

June 19, 2009 – Medtronic Inc. today said it received CE (Conformité Européenne) mark for the company's second-generation pacemaker designed, tested, approved for use as labeled with MRI machines, the Advisa DR MRI SureScan pacing system. The Advisa MRI SureScan pacing system currently is not available for sale in the U.S.

June 19, 2009 - Barco has won a substantial order for the supply of medical displays for a new PACS system to be installed at Tokyo Women's Medical University Medical Center East in Japan.

June 18, 2009 - Researchers at the Heart and Vascular Institute and the Imaging Institute at the Cleveland Clinic in Ohio said stress imaging remains the most acceptable noninvasive technique for diagnosis of in-stent restenosis (ISR) based on a meta-analysis using available studies to determine the diagnostic efficacy of 64-slice computed tomography (CT) in evaluation of ISR.

June 18, 2009 - A leading Danish cancer hospital has treated its first patient using RapidArc radiotherapy after installing eight advanced radiotherapy treatment machines from Varian Medical Systems of Palo Alto, Calif. Herlev Hospital, to the northwest of Copenhagen, delivered the fast and efficient RapidArc treatment to a prostate cancer patient using a Clinac iX linear accelerator.

June 18, 2009 – GE Healthcare this week launched its Stimulus Simplicity program, which offers healthcare providers interest-free loans with deferred payments to purchase electronic medical records (EMRs) and a certification warranty to ensure the EMRs will meet any guidelines set for meaningful use.

June 17, 2009 – Molecular Insight Pharmaceuticals Inc. presented clinical data on a radiolabeled, small-molecule molecular imaging pharmaceutical in development for diagnosis and staging of prostate cancer at the 2009 annual meeting of the Society of Nuclear Medicine (SNM) in Toronto.